Cisen Pharmaceutical Co Ltd (603367) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million ≈ $45.64 Million USD) by net assets (CN¥6.19 Billion ≈ $906.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603367 net asset quality index to measure how much of total assets are equity-financed.

Cisen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603367 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sdiptech AB (publ) ST:SDIP-B	0.029x
NCC Limited NSE:NCC	-0.174x
NanJing Pharmaceutical Co Ltd SHG:600713	-0.119x
GuangZhou BaiYun Elec Equip Co SHG:603861	-0.017x
Gui Zhou Tyre Co Ltd SHE:000589	0.040x
Redcare Pharmacy NV F:RDC	-0.039x
SeAH Bestee KO:001430	0.007x
Beijing Watertek Information Technology Co Ltd SHE:300324	0.004x

Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Cisen Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.23 Billion ≈ $911.75 Million	CN¥466.37 Million ≈ $68.25 Million	0.075x	-21.50%
2024-12-31	CN¥5.99 Billion ≈ $876.08 Million	CN¥570.85 Million ≈ $83.53 Million	0.095x	+21.85%
2023-12-31	CN¥5.77 Billion ≈ $843.81 Million	CN¥451.24 Million ≈ $66.03 Million	0.078x	+62.23%
2022-12-31	CN¥5.36 Billion ≈ $783.73 Million	CN¥258.35 Million ≈ $37.80 Million	0.048x	+4.39%
2021-12-31	CN¥5.06 Billion ≈ $739.79 Million	CN¥233.60 Million ≈ $34.18 Million	0.046x	-48.52%
2020-12-31	CN¥4.80 Billion ≈ $702.68 Million	CN¥431.01 Million ≈ $63.07 Million	0.090x	+126.48%
2019-12-31	CN¥4.57 Billion ≈ $669.29 Million	CN¥181.26 Million ≈ $26.52 Million	0.040x	-59.51%
2018-12-31	CN¥4.15 Billion ≈ $608.01 Million	CN¥406.68 Million ≈ $59.51 Million	0.098x	-17.08%
2017-12-31	CN¥3.72 Billion ≈ $544.98 Million	CN¥439.61 Million ≈ $64.33 Million	0.118x	-7.08%
2016-12-31	CN¥2.30 Billion ≈ $336.34 Million	CN¥291.97 Million ≈ $42.72 Million	0.127x	+0.13%
2015-12-31	CN¥2.10 Billion ≈ $307.11 Million	CN¥266.24 Million ≈ $38.96 Million	0.127x	+775.81%
2014-12-31	CN¥1.90 Billion ≈ $278.19 Million	CN¥27.54 Million ≈ $4.03 Million	0.014x	-69.23%
2013-12-31	CN¥1.73 Billion ≈ $252.63 Million	CN¥81.26 Million ≈ $11.89 Million	0.047x	+125.43%
2012-12-31	CN¥1.58 Billion ≈ $231.88 Million	CN¥33.09 Million ≈ $4.84 Million	0.021x	-63.20%
2011-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥76.28 Million ≈ $11.16 Million	0.057x	--

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$973.91 Million

CN¥6.66 Billion CNY

Market Cap Rank

#9030 Global

#2219 in China

Share Price

CN¥14.70

Change (1 day)

+1.10%

52-Week Range

CN¥12.45 - CN¥34.05

All Time High

CN¥34.05